[6]
Bray, F.; Soerjomataram, I. Transitions in human development and the global cancer burden.World Cancer Report 2014 ; Stewart, B.W.; Wild, C.P., Eds.; IARC Press: Lyon, 2014, pp. 42-55.
[11]
Husemann, T.; Flückiger, F.A. Pharmacographia. A history of the principal drugs of vegetable origin, met with in Great Britain and British India. Arch. Pharm., 1880, 216, 235-238.
[13]
Niness, K.R. Inulin and oligofructose: what are they? Zucker., 1952, 5, 30-33.
[15]
Kruger, C.L. Generally Recognized as Safe (GRAS) notification for
Frutafit, Food and Drug Administration: Arlington, VA, 2002.
[16]
Surveillance, Epidemiology, and End Results (SEER) Program.
SEER*stat database:. mortality-all cod, aggregated with state, total
US (1969-2010) National Cancer Institute, division of cancer control
and population sciences, surveillance research program. Cancer
Statistics Branch, 2013.
[17]
Surveillance, E.; Results, E. (SEER) Program. SEER*Stat Database: Incidence-SEER 9 Regs Public Use, Nov. 2011 Sub (1973-2010)-Linked to County Attributes-Total US, 1969-2011 Counties; National Cancer Institute, division of cancer control and population sciences; Surveillance Research Program, Cancer Statistics Branch: Bethesda, MD, 2013.
[18]
Maxwell, P.; Freddie, D.; Jacques, F.; Paola, P. Estimating the world cancer burden: Globocan2000. Int. J. Cancer, 2001, 94(2), 153-156.
[19]
United States Cancer Statistics:. 1999-2008 incidence and mortality
web-based report. Atlanta: Centres for Disease Control and Prevention;
National Cancer Institute.CDC (Centres for Disease Control
and Prevention); , 2012.
[20]
Lindsey, A.; Torre, MSPH.; Freddie, B.R.; Siegel, MPH.; Jacques, F.; JoannieLortet-Tieulent, M.E.; Ahmedin, J. On global cancer statistics, 2012. Cancer J. Clin., 2015, 65, 87-108.
[24]
Atlanta, G.A. Centres for disease control and prevention, National centre for chronic disease prevention and health promotion. 2012 Behavioural Risk Factor Surveillance System (BRFSS) Public Use Data Tapes; Centres for Disease Control and Prevention, 2013.
[25]
Surveillance Research Program, National Cancer Institute. SEER* Stat software. Version 8.1.2; National Cancer Institute: Bethesda, MD, 2013.
[26]
World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR). Continuous Update Project Report: Diet, Nutrition, Physical Activity and Colorectal Cancer 2016. Revised 2018; World Cancer Research Fund International: London, 2018.
[28]
Surveillance, E.; Results, E. (SEER) Program SEER*Stat Database:
North American Association of Central Cancer Registries
(NAACCR) Incidence-CiNA Analytic File, 1995-2010, for Expanded
Races, custom file with county, ACS Facts & Figures projection
project, North American Association of Central Cancer
Registries, National Cancer Institute, Division of Cancer Control
and Population Sciences, Surveillance Research Program, Cancer
Statistics Branch: Bethesda, MD. 2013.
[32]
Freddie, B.; Jacques, F.; Isabelle, S. Global cancer statistics GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries., 2018.
[34]
Beringer, A.; Wenger, R. Inulin in der ernahrung des diabetikers. Dutch. Z. Verdauungs Stofwechselkrankh. J. Nutr., 1995, 15, 268-272.
[35]
Hoebregs, H. Fructans in foods and food products, ion-exchange chromatographic method: collaborative study. Joint commission of biochemical nomenclature abbreviated terminology of oligosaccharide chains. J. Biol. Chem., 1982, 257, 1029-1037.
[38]
Murphy, N.; Ward, H.A.; Jenab, M.; Rothwell, J.A.; Boutron-Ruault, M.C.; Carbonnel, F.; Kvaskoff, M.; Kaaks, R.; Kühn, T.; Boeing, H.; Aleksandrova, K.; Weiderpass, E.; Skeie, G.; Borch, K.B.; Tjønneland, A.; Kyrø, C.; Overvad, K.; Dahm, C.C.; Jakszyn, P.; Sánchez, M.J.; Gil, L.; Huerta, J.M.; Barricarte, A.; Quirós, J.R.; Khaw, K.T.; Wareham, N.; Bradbury, K.E.; Trichopoulou, A.; La Vecchia, C.; Karakatsani, A.; Palli, D.; Grioni, S.; Tumino, R.; Fasanelli, F.; Panico, S.; Bueno-de-Mesquita, B.; Peeters, P.H.; Gylling, B.; Myte, R.; Jirström, K.; Berntsson, J.; Xue, X.; Riboli, E.; Cross, A.J.; Gunter, M.J. Heterogeneity of colorectal cancer risk factors by anatomical sub site in 10 European countries: a multinational cohort study.
Clin. Gastroenterol. Hepatol., 2019,
17(7), 1323-1331.e6.
[
http://dx.doi.org/10.1016/j.cgh.2018.07.030] [PMID:
30056182]
[40]
Edge, S.; Byrd, D.R.; Compton, C.C.; Fritz, A.G.; Greene, F.L.; Trotti, A. Colon and rectum.Springer; Cancer Staging Manual, A.J.C.C., Ed.; NY, USA, 2014, pp. 143-164.
[48]
Gabriel, A.; Kune, A. The nutritional causes of colorectal cancer: an
introduction to the Melbourne study by Department of Surgery,
University of Melbourne, Repatriation General Hospital, Heidelberg,
Victoria, Australia, 2009.
[53]
International Agency for Research on Cancer (IARC) Globocan 2018. Cancer Fact Sheets-. Colorectal Cancer, 2018.
[69]
Ries, L.A.G.; Melbert, D.; Krapcho, M.; Stinchcomb, D.G.; Howlader, N.; Horner, M.J.; Mariotto, A. Processed meat and colorectal cancer: a review of epidemiologic and experimental evidence. Nutr. Cancer, 2008, 60, 131-144.
[73]
National Institutes of Health.. What You Need to Know About Cancer
of the Colon and Rectum; U.S. Department of Health and Human
Services & National Institutes of Health: Bethesda, MD 2006.
[74]
Skibber, J.; Minsky, B.; Hoff, P. Cancer of the colon and rectum.Cancer: Principles & Practice of Oncology, 6th Ed; DeVita, V.T.Jr.; Hellmann, S.; Rosenberg, S.A., Eds.; Lippincott Williams & Wilkins:
Philadelphia, 2001, pp. 1216-1271.
[76]
World Cancer Research Fund and American Institute for Cancer Research.. Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective Washington; American Institute for Cancer Research: DC, 2007.
[86]
Stoffel, E.; Mukherjee, B.; Raymond, V.M.M.; Tayob, N.; Kastrinos, F.; Sparr, J. Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome. Gastroenterology, 2009, 137(5), 1621-1627.
[110]
The Declaration of Certain Isolated or Synthetic Non-Digestible
Carbohydrates as Dietary Fiber on Nutrition and Supplement Facts
Labels.United States Food and Drug Administration, Guidance for
Industry; Availability, 2018, pp. 1-8.
[112]
Koruri, S.S.; Banerjee, D.; Chowdhury, R.; Bhattacharya, P. Studies on prebiotic food additive (inulin) in Indian dietary fibre sources - Garlic (Allium sativum), Wheat (Triticum spp.), oat (Avena sativa) and dalia (Bulgur). Int. J. Pharma Sci., 2014, 6, 278-282.
[114]
Belval, H. Industrie de l‘inuline et du le’vulose. Dix ans dƒ??efforts scientifiques; industriels et coloniaux.Adv. Food Nutr. Res; , 1927, pp. 1068-1069.
[121]
Petkova, N.; Ognyanov, M.; Denev, P. Academy of isolation and characterization of inulin obtained from taproot of common chicory, Chicoriumintybus L.Bulgaria Scientific Paper; , 2014, 39, pp. 25-34.
[122]
Lis, D.G.; Preston, L.A.U.S. Patent No. 5,840,884. Washington,
D.C.; U.S Patent and Trademark Office, 1998.
[123]
U.S. Patent No.5, 840, 884.Washington, D.C.; U.S Patent and
Trademark Office.
[126]
Turner, E.; Munro, A.G.; Comfort, P. Female soccer: Part 1- A needs analysis. Strength Condit. J., 2013, 35(1), 51-57.
[128]
Leyva, P.C.; LÓpez, P.A.L.; Alvarez, S.C.; Pére, U.C.; Leos, Z.S. Physical properties of inulin and technological applications.Polysacch.
Bioactivity Biotechnol; , 2015, pp. 959-984.
[154]
Chien, Y.W. Oral drug delivery and delivery systems; Novel Drug Del. Sys, 1992, pp. 139-196.
[160]
Basit, A.; Bloor, J. Perspectives on colonic drug delivery, business briefing.Pharm. Tech; , 2003, pp. 185-190.
[161]
Park, K.; Shalaby, W.S.W.; Park, H. Biodegradation in: Biodegradable hydrogels in drug delivery. Adv. Drug Deliv. Rev., 1993, 11, 13-34.
[180]
Srinarong, P.; Homellinen, S.; Visser, M.R.; Hinrichs, W.L.; Ketolainen, J.; Frijlink, H.W. Surface active derivative of inulin (Inutec® SP1) is a superior carrier for solid dispersions with a high drug load. J. Pharmceut. Sci., 2011, 100, 2333-2342.
[181]
Laura, M.D.; Mohaca, B.; Roberto, C.; Francesco, C.P.; Gennara, C.; Gaetano, G.; Mariano, L. Multicomponent solid dispersion as a formulation strategy to improve drug permeation: a case study on the anti-colorectal cancer. J. Drug Del. Sci., 2019, 52, 346-354.